Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses

Pharmacopsychiatry

Volumn 29, Issue 3, 1996, Pages 87-96

  Stassen, H H ^a   Angst, J ^a   Delini Stula, A ^b  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; IMIPRAMINE; MOCLOBEMIDE; OXAPROTILINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTICENTER STUDY; PRIORITY JOURNAL; TIME;

EID: 0029875776     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979551     Document Type: Article

References (30)

1. Angst, J.: Time-lag of antidepressant effect. In: Symposia Medica Hoechst 13, Symposium Rome 1977: Depressive Disorders. Stuttgart, Schattauer (1978) 468
2. Angst, J., A. Delini-Stula, H. H. Stassen: Is a cutoff score a suitable measure for treament outcome? A methodological meta-analysis. Human Psychopharmacology 8 (1993) 311-317
3. Angst, J., H. H. Stassen: Methodische Aspekte von Studien zur antidepressiven Wirksamkeit. In: Steinberg R., M. Philipp, H.-J. Möller (eds.) Spezielle Aspekte der antidepressiven Therapie. MMV Medizin Verlag, München (1994) 147-166
4. Blier, P., C. de Montigny, Y. Chaput: A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. J. Clin. Psychiatry 51 (1990) 14-20
5. Donlon, P. T., H. Biertuemphel, M. Willenbring: Amoxapine and amitriptyline in the outpatient treatment of endogenous depression. J. Clin. Psychiatry 42 (1981) 11-15
6. Delini-Stula, A., K. Hauser, P. Baumann, H. P. Olpe, P. Waldmeier, A. Storni: Stereospecificity of behavior and biochemical responses to oxaprotiline - a new antidepressant. Adv. Biochem. Psychopharmacol. 31 (1982) 265-275
7. Entsuah, A. R., M. M. Bradley, G. S. Littman: Cumulative mean change procedure: application to a comperative trial of venlafaxine, imipramine, and placebo in the treatment of major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 18 (1994) 695-706
8. Gachoud, J. P., H. Mikkelsen, S. Ammar, D. Widlöcher, R. Jouvent: Theoretical consideration and perspectives on the onset of action of moclobemide. Psychopharmacology 106 (1992) 96-97
9. Greenhouse, J. B., D. J. Kupfer, E. Frank, D. B. Jarrett, K. A. Rejman: Analysis of time to stabilization in the treatment of depression: biological and clinical correlates. J. Affect. Disord. 13 (1987) 259-266
10. Greenhouse, J. B., D. Stangl, J. Bromberg: An introduction to survival analysis: statistical methods for analysis of clinical trial data. J. Cons. Clin. Psychology 57 (1989) 536-544
11. Grey, P.: Fluoxetine and onset of its therapeutic effect. Am. J. Psychiatry 150 (1993) 984
12. Hekimian, L. J., A. J. Friedhoff, E. Deever: A comparison of the onset of action and therapeutic efficacy of amoxapine and amitriptyline. J. Clin. Psychiatry 39 (1978) 633-637
13. Katz, M. M., S. H. Koslow, J. M. Maas, A. Frazer, C. L. Bowden, R. Casper, J. Croughan, J. Kocsis, E. Redmond jr.: The timing, specificity and clinical prediction of tricycling drug effects in depression. Psychol. Med. 17 (1987) 297-309
14. Khan, A., S. Cohen, S. Dager, D. H. Avery, D. L. Dunner: Onset of response in relation to outcome in depressed outpatients with placebo and imipramine. J. Affect. Disord. 17 (1989) 33-38
15. Laska, E. M., C. Siegel, A. Sunshine: Onset and duration: Measurement and analysis. Clin. Pharmacol. Ther. 49 (1991) 1-5
16. Laska, E. M., M. J. Meisner: Nonparametric estimation and testing in a cure model. Biometrics 48 (1992) 1223-1234
17. Mason, B. J., J. H. Kocsis, A. J. Frances, J. J. Mann: Amoxapine versus amitriptyline for continuation therapy of depression. J. Clin. Psychopharmacol. 10 (1990) 338-343
18. Meltzer, H. Y: Psychopharmacology: the third generation of progress. New York, Raven Press (1987)
19. Meya U., K. Fichte: Antidepressiver Wirkungseintritt von Rolipram, einem Antidepressivum mit einem neuen Wirkmechanismus, im Vergleich zu Imipramin. Nervenarzt 62 (1991) 288-291
20. Montgomery, S. A.: Rapid onset of action of venlafaxine. Int. Clin. Psychopharmacol. 10, Suppl. 2 (1995) 21-27
21. Quitkin, F. M., J. D. Rabkin, J. M. Markowitz, J. M. Stewart, P. J. McGrath, W. Harrison: Use of pattern analysis to identify true drug response. Arch. Gen. Psychiatry 44 (1987) 259-264
22. Quitkin, F. M., J. G. Rabkin, J. W. Stewart, P. J. McGrath, W. Harrison, D. C. Ross, E. Tricamo, J. Fleiss, J. Markowitz, D. F. Klein: Heterogeneity of clinical response during placebo treatment. Am. J. Psychiatry 148 (1991) 193-196
23. Quitkin, F. M., P. J. McGrath, J. G. Rabkin, J. W. Stewart, W. Harrison, D. C. Ross, E. Tricamo, J. Fleiss, J. Markowitz, D. F. Klein: Different types of placebo response in patients receiving antidepressants. Am. J. Psychiatry 148 (1991) 197-203
24. Quitkin, F. M., J. W. Stewart, P. J. McGrath, E. Nunes, K. Ocepek-Welikson, E. Tricamo, J. G. Rabkin, D. F. Klein: Further evidence that a placebo response to antidepressants can be identified. Am. J. Psychiatry 150 (193) 566-570
25. Roffmann, M., E. F. Gould, S. J. Brewer, H. Lau, B. Sachais, R. B. Dixon, L. Kaczmarek, A. Lesher: A double blind comparative study of oxaprotiline with amitriptyline and placebo in moderate depression. Cur Ther. Res. 32 (1982) 247-256
26. Stassen, H. H., A. Delini-Stula, J. Angst: Time course of improvement under antidepressant treatment: a survival-analytical approach. Eur. Neuropsychopharmacol. 3 (1993) 127-135
27. Stassen, H. H., J. Angst, A. Delini-Stula: Severity at baseline and onset of improvement in a depression. Meta-analysis of imipramine and moclobemide versus placebo. Eur. Psychiatry 9 (1994) 129-136
28. Tollefson, G. D., S. L. Holman: How long to onset of antidepressant action: a meta-analysis of patients treated with fluoxetine or placebo. Int. Clin. Psychopharmacol. 9 (1994) 245-250
29. Waldmeier, P. C., P. A. Baumann, K. Hauser, L. Maître, A. Storni: Oxaprotiline, a nonadrenaline uptake inhibitor with an active and inactive enantiomer. Biochem. Pharmacol. 31 (1982) 2169-2176
30. Willner, P.: Sensitization of the actions of antidepressant drugs. Psychoactive Drugs (1989) 407-453